Citi are highlighting the regulatory risk facing A2 Milk around re-registration of IF products by early next year
Printable View
Citi are highlighting the regulatory risk facing A2 Milk around re-registration of IF products by early next year
A clue of some stability in A2??
from today's SML's FY22 guidance statement...
FY22 guidance statement:
Synlait still expects its Net Profit After Tax result to return to robust profitability in FY22 based on:
• Tighter management of its Ingredient business;
• Improved infant base powder volumes;
• A growing contribution from its Lactoferrin and Consumer Foods businesses; and
• Retained cost savings.
Does anyone involved have any recent updates in the class action law suits?
Some encouraging news this week
1 - Synlait seeing improved infant base powder volumes today
2 - A2 win another court case https://www.ashurst.com/en/news-and-...2-trade-marks/
3 - Ausnutria report out this week seeing category in $$$ terms up 2.2% in 2021 and a gradual lift in birth rate over the next 2-3 years.
Attachment 13666Attachment 13667
Any Court action will be thrown out. Angry shareholders need to move on